Clinical Professor of Medicine, David Geffen School of Medicine, UCLA Cedars-Sinai Heart Institute
Cardiology
Dr. Charles D. Swerdlow, MD
|
|
Give Review
Doctor Charles D. Swerdlow, MD works in the field of Cardiology. He graduated from Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received 6 awards: "America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:Southern California", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Super Doctor". Charles Swerdlow is a published MD as well. He has 101 publications published. The latest was: Current concepts of ventricular defibrillation. He accepts all Medicare patients.
Publications
- Sinus R-Wave Amplitude as A Predictor of Vf Undersensing in Implantable Cardioverter-Defibrillator Patients.
- Troubleshooting Implantable Cardioverter-Defibrillator Sensing Problems II.
- Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications.
- Troubleshooting implanted cardioverter defibrillator sensing problems I.
- Intramural outflow tract ventricular tachycardia: anatomy, mapping, and ablation.
- Isthmus-Dependent Atrial Flutter with Unusual Activation Pattern.
- Implantable cardioverter-defibrillator leads: design, diagnostics, and management.
- Inside-out insulation Failure of a defibrillator lead with abrasion-resistant coating.
- Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads.
- Approach to the difficult septal atrioventricular accessory pathway: the importance of regional anatomy.
- A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or Fibrillation due to T-wave oversen...
- Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming.
- Intracardiac QT integral on far-field ICD electrogram predicts sustained ventricular tachyArrhythmias in ICD patients.
- Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics.
- Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyArrhythmias in implantable cardioverter-defibrillator patients: a p...
- Antitachycardia pacing in primary-prevention ICDs.
- Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study.
- Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
- Combined Atrial and ventricular antitachycardia pacing as a novel method of rhythm discrimination: the Dynamic Discrimination Download Study.
- TASER conducted electrical weapons and implanted pacemakers and defibrillators.
- Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
- Presenting rhythm in sudden deaths temporally proximate to discharge of TASER conducted electrical weapons.
- High sensing integrity counter in a patient with a Sprint Fidelis deFibrillation lead: what is the cause?
- The changing presentation of implantable cardioverter-defibrillator lead fractures.
- Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
- The Sprint Fidelis lead fracture story: what do we really know and where do we go from here?
- Automatic determination of timing intervals for upper limit of vulnerability using ICD electrograms.
- High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or Fibrillation in ICD electrograms.
- Taser-induced rapid ventricular Myocardial capture demonstrated by pacemaker intracardiac electrograms.
- Small-diameter defibrillation electrodes: can they take a licking and keep Hearts ticking?
- Optimizing deFibrillation waveforms for ICDs.
- The dilemma of ICD implant testing.
- Using the upper limit of vulnerability to assess deFibrillation efficacy at implantation of ICDs.
- Effect of programmed number of intervals to detect ventricular Fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks.
- Antidromic reciprocating tachycardia: what is the mechanism of termination?
- Radiofrequency catheter ablation and nerve growth factor concentration in humans.
- ICD waveforms: what really matters?
- Detection of T-wave alternans using an implantable cardioverter-defibrillator.
- Advanced ICD troubleshooting: Part II.
- Advanced ICD troubleshooting: Part I.
- Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators.
- Counterclockwise Atrial flutter in dextrocardia.
- Percutaneous epicardial mapping during ablation of difficult accessory pathways as an alternative to cardiac surgery.
- Improved deFibrillation efficacy with an ascending ramp waveform in humans.
- Reappraisal of implant testing of implantable cardioverter defibrillators.
- Left ventricular endocardial lead placement using a modified transseptal approach.
- Acceleration of ventricular rate following Atrial antitachycardia pacing: what is the mechanism?
- Discrepancies between the upper limit of vulnerability and deFibrillation threshold: prevalence and clinical predictors.
- Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
- Electrical shocks to the arm elicit and inhibit startle eyeblinks.
- Early recurrence of Atrial fibrillation after ambulatory shock conversion.
- Optimizing deFibrillation waveforms.
- Determinants of first-shock success for Atrial implantable cardioverter defibrillators.
- Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of impla...
- Cardiovascular collapse caused by electrocardiographically silent 60-Hz intracardiac leakage current. Implications for electrical safety.
- Current concepts of ventricular deFibrillation.
- Effect of shock waveform on relationship between upper limit of vulnerability and deFibrillation threshold.
- Application of models of deFibrillation to human deFibrillation data: implications for optimizing implantable defibrillator capacitance.
- Atypical atrioventricular node reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway.
- The zone of vulnerability to T wave shocks in humans.
- Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
- Upper limit of vulnerability predicts chronic deFibrillation threshold for transvenous implantable defibrillators.
- Comparative reproducibility of deFibrillation threshold and upper limit of vulnerability.
- Charge-burping theory correctly predicts optimal ratios of phase duration for biphasic deFibrillation waveforms.
- Short biphasic pulses from 90 microfarad capacitors lower deFibrillation threshold.
- Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful deFibrillation in humans with transvenous implantable ...
- Anatomical findings in patients having had a chronically indwelling Coronary sinus defibrillation lead.
- Relation between upper limit of vulnerability and deFibrillation threshold in humans.
- Discrimination of ventricular tachycardia from sinus tachycardia and Atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
- Effects of voltage and respiration on impedance in nonthoracotomy deFibrillation pathways.
- Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator.
- Upper limit of vulnerability reliably predicts the deFibrillation threshold in humans.
- Effect of capacitor size and pathway resistance on deFibrillation threshold for implantable defibrillators.
- Arrhythmias after cardioverter-defibrillator implantation: comparison of epicardial and transvenous systems.
- Optimal electrode configuration for pectoral transvenous implantable defibrillator without an active can.
- Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus.
- Programmed ventricular stimulation in predicting vulnerability to ventricular Arrhythmias and their response to antiarrhythmic therapy.
- The automatic implantable defibrillator: local ventricular bipolar sensing to detect ventricular tachycardia and Fibrillation.
- Prognostic significance of the number of induced ventricular complexes during assessment of therapy for ventricular tachyArrhythmias.
- Safety and efficacy of intravenous quinidine.
- Efficacy of verapamil in Chronic, recurrent ventricular tachycardia.
- Determinants of survival in patients with ventricular tachyArrhythmias.
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory Arrhythmias.
- Clinical factors predicting successful electrophysiologic-pharmacologic study in patients with ventricular tachycardia.
- Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
- Clinical efficacy and electrophysiology of imipramine for ventricular tachycardia.
- Entrainment of ventricular tachycardia.
- Rupture of a coronary bypass graft Aneurysm: CT evaluation and coil occlusion therapy.
- Facilitation of ventricular tachyarrhythmia induction by isoproterenol.
- Prospective comparison of Holter monitoring and electrophysiologic study in patients with Coronary artery disease and sustained ventricular tachyarrhythmias.
- Determinants of prognosis in ventricular tachyarrhythmia patients without induced sustained Arrhythmias.
- Long-term follow-up after surgical correction of Wolff-Parkinson-White Syndrome.
- Results of operations for ventricular tachycardia in 105 patients.
- Summation and inhibition by ultrarapid train pacing in the human ventricle.
- Determinants of induced sustained Arrhythmias in survivors of out-of-hospital ventricular fibrillation.
- Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia.
- Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyArrhythmias.
- Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior Myocardial infarction.
- Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different ...
- Implantable Cardiac Defibrillator Lead Failure and Management.
Schools
Harvard Medical School
La Co Harbor Genl Hospital
Stanford Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:Southern California
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Super Doctor
Education
-
Stanford University -
Harbor - UCLA Medical Center -
Harvard Medical School -
Stanford
Hospital
-
Ronald Reagan UCLA Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1497727309 | |
| NPPES Provider LastName | SWERDLOW | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 902104532 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 758.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497727309 |
| Last Name Of The Provider | SWERDLOW |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
Dr. Shahram F. Ravan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Helfenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Satinder S. Bhatia, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arash Bereliani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Debra R. Judelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Frisch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reed S. Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj M. Khandwalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard N. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheri Koplik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence S. Czer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jorge A. Levisoan, MD |
|
Dr. Suhail Y. Dohad, MD
This Doctor is OpenDoctor Recommended.
|